Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
Ms. Sjogren brings nearly 30 years of biopharmaceutical experience building commercial organizations and leading successful oncology launches Pending acquisition of AnHeart Therapeutics and expanded leadership strongly positions Nuvation Bio to potentially become a commercial organization by the end of 2025 March 28, 2024 08:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs … Continue reading Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer